Novavax - Articles and news items

Novavax’s RSV vaccine safe for foetus; company gets $89m funding

Industry news / 29 September 2015 / Victoria White

Infants received a significant bolus of all anti-RSV antibodies via transplacental transfer. As such, the RSV F Vaccine demonstrates the potential to protect infants when they are most at risk of infection…

Novavax announces positive top-line data from Phase 1 Ebola vaccine trial

Industry news / 22 July 2015 / Victoria White

Novavax has announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein recombinant nanoparticle vaccine candidate…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+